Mycophenolate mofetil Completed Phase 3 Trials for Uveitis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01829295Methotrexate and Mycophenolate Mofetil for UVEITIS
NCT01232920First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial